SO
TARO

STRS Ohio’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

STRS Ohio’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,300
Closed -$521K – 2128
2024
Q1 		$521K Sell
12,300
-800
-6% -$33.7K ﹤0.01% 1232
2023
Q4 		$547K Buy
13,100
+10,400
+385% +$383K ﹤0.01% 1239
2023
Q3 		$101K Buy
2,700
+1,000
+59% +$37.5K ﹤0.01% 1713
2023
Q2 		$64K Buy
+1,700
New +$53.4K ﹤0.01% 1780
2016
Q4 		– Sell
-13,400
Closed -$1.48M – 2001
2016
Q3 		$1.48M Buy
+13,400
New +$1.77M 0.01% 678

Other funds holding TARO

KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $1.65B AUM 25.75% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

STRS Ohio's TARO Position: Q2 2024 in Review

STRS Ohio sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 12,300 shares — an estimated $521K sold.

STRS Ohio first reported a position in TARO in Q3 2016 and held it in 5 quarters. The position peaked at $1.48M in Q3 2016. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • STRS Ohio reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • STRS Ohio sold 12,300 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $521K.
  • STRS Ohio first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2016 and held it in 5 quarters.
  • STRS Ohio's Taro Pharmaceutical Industries Ltd. position peaked at $1.48M in Q3 2016.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on STRS Ohio's 13F filing for Q2 2024, filed 5 Aug 2024.